Search results for: “biotech”
-
Etalon Group acquires land Novosibirsk for residential development
•
MOSCOW: Etalon Group, one of Russia’s largest and longest-established development and construction companies, has acquired a 26-hectare land…
-
Pyxis Oncology prices Nasdaq IPO at $16/share
•
LONDON, UK: Arix Bioscience plc, a global venture capital company focused on investing in and building breakthrough biotech…
-
Agronomics leads leather producer VitroLabs Series A Funding round
•
LONDON, UK: Agronomics has led portfolio company VitroLabs Inc’s Series A funding round with a 7.0 million investment.…
-
Oncimmune signs agreement to profile patients
•
LONDON, UK: Oncimmune Holdings has signed an autoantibody profiling agreement with a leading global pharmaceutical company to evaluate…
-
Cizzle signs research agreement with University of York
•
LONDON, UK: Cizzle Biotechnology, the UK based diagnostics developer, has entered into a new research agreement with the…
-
Arqit Quantum announce business combination with Centricus Acquisition
•
NEW YORK: Arqit Quantum Inc. announced the completion of its business combination with Centricus Acquisition Corp., a special…
-
Lisa McIntyre appointed to Fisher & Paykel Healthcare Board
•
AUCKLAND, NEW ZEALAND: Fisher & Paykel Healthcare Corporation Limited advises that Lisa McIntyre, PhD, has been appointed as…
-
Alternus Energy appoints Tone Bjørnov to BoD
•
DUBLIN, IRELAND: Alternus Energy Group announced the appointment of Tone Bjørnov as a non-Executive Board Director with immediate…
-
HUTCHMED selected for certain Hang Seng Indexes
•
HONG KONG: HUTCHMED (China) Limited announced that HUTCHMED has been selected as a constituent stock of several indexes…
-
3D Systems to sell Simbionix to Surgical Science Sweden for $305 million
•
ROCK HILL: 3D Systems has signed a definitive agreement to sell its medical simulation business, Simbionix, to Surgical…
-
Håvard Lindstrøm appointed CEO of Aqua Bio Technology
•
OSLO, NORWAY: As Aqua Bio Technology (ABT) moves from a development and production phase to a commercial phase…
-
EQT Private Equity and Goldman Sachs to acquire Parexel for $8.5 billion
•
BOSTON: Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.